$1.5m non-dilutive ARC funding for manufacturing
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Nexsen Limited has secured funding to support its manufacturing and platform optimisation efforts. Nexsen will collaborate with SAGE-Manufacturing to enhance its diagnostic capabilities through advanced catalysis science. This partnership aligns with Nexsen's goal to expand its research and development capacity while minimizing costs to shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Nexsen
- Nexsen secures first hospital partner in Asia
- Nexsen and Universiti Malaya launch joint facility
- Quarterly Report - Q3 FY26
- QMS milestone achieved
- HK$6 million grant awarded to advance Asia-Pacific execution
Later from Nexsen
- Quarterly Report - Q4 FY26
- Corporate Governance Statement and Appendix 4G
- Annual Report - FY 2026
- Notification regarding unquoted securities - NXN
- Director Interest Notices re Performance Rights
Follow Nexsen into a list and get an email when it puts out news.
Follow Nexsen